Halozyme Therapeutics Inc. Common Stock vs SK Telecom Co. Ltd. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while SK Telecom Co. Ltd. Common Stock trades at $34.56 (market cap $13.36B). The key difference: Halozyme Therapeutics Inc. Common Stock and SK Telecom Co. Ltd. Common Stock are close in size by market cap, and SK Telecom Co. Ltd. Common Stock pays a 2.85% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and SK Telecom Co. Ltd. Common Stock for 1 Days on average.
| HALO | SKM | |
|---|---|---|
Market Cap | $12.58B | $13.36B |
Volume | 2,179,278 | 1,302,042 |
Sector | Health | Media |
52-Week High | $115.22 | $46.00 |
52-Week Low | $61.63 | $19.68 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $19.41B |
Dividend Yield | — | 2.85% |
Trailing returns across standard periods
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →SK Telecom is a South Korean telecommunications company providing mobile, broadband, and digital services. It also develops services in areas such as AI, cloud, and data centers.
Read more on SKM →